Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

6.1%

2 terminated out of 33 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

15%

5 trials in Phase 3/4

Results Transparency

27%

3 of 11 completed with results

Key Signals

3 with results85% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (6)
Early P 1 (1)
P 1 (1)
P 2 (4)
P 3 (4)
P 4 (1)

Trial Status

Completed11
Recruiting8
Unknown8
Terminated2
Not Yet Recruiting2
Active Not Recruiting1

Trial Success Rate

84.6%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT06672237Phase 3Recruiting

A Phase 3 Study of NTLA-2001 in ATTRv-PN

NCT06563895Phase 3Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT07493681CompletedPrimary

ChatGPT in the Diagnosis and Management of Complex Polyneuropathies: Comparative Analysis With Neurologists Using Real-World Cases

NCT03617185Not ApplicableCompletedPrimary

Effect of Exercise and Surgical Weight Loss on Polyneuropathy

NCT05023889Early Phase 1Active Not RecruitingPrimary

Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy

NCT04064983UnknownPrimary

Individual Patient Expanded Access IND to Treat Polyneuropathy

NCT07166302Recruiting

Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy

NCT07116473Phase 3Not Yet Recruiting

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

NCT06377033Not ApplicableRecruiting

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

NCT03237494Completed

TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects

NCT06040567Recruiting

Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study

NCT06754995RecruitingPrimary

Diagnostic Feasibility of 100 Hz Tetanic Stimulation

NCT06359561Enrolling By Invitation

Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients with Cervical Lead Placement

NCT06390527Not Yet RecruitingPrimary

Ultrasonography in Diagnosis of Polyneuropathy

NCT06044662RecruitingPrimary

Prognostic Value of Biomarkers in Polyneuropathy.

NCT03862365Recruiting

Exploring the Genetics of Neuropathic Pain

NCT04664426CompletedPrimary

Sensory Neuropathy Scores Validated by Quantitative Sensory Testing and Nerve Conduction Studies for Kidney Transplant Recipients

NCT05188690Unknown

Polyneuropathy and COVID-19

NCT02753036Unknown

Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer

NCT04461613Not ApplicableUnknown

Physical Activity in Persons With Charcot-Marie-Tooth: Developing a Measurement Instrument

Scroll to load more

Research Network

Activity Timeline